DK2262486T3 - Quetiapin sammensætning - Google Patents

Quetiapin sammensætning

Info

Publication number
DK2262486T3
DK2262486T3 DK09777586.0T DK09777586T DK2262486T3 DK 2262486 T3 DK2262486 T3 DK 2262486T3 DK 09777586 T DK09777586 T DK 09777586T DK 2262486 T3 DK2262486 T3 DK 2262486T3
Authority
DK
Denmark
Prior art keywords
quetiapine
composition
quetiapine composition
Prior art date
Application number
DK09777586.0T
Other languages
English (en)
Inventor
Matej Pavli
Rok Dreu
Sasa Baumgartner
Odon Planinsek
Robert Pisek
Franc Vrecer
Miha Vrbinc
Original Assignee
Krka Tovarna Zdravil D D Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41112567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2262486(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SI200800193A external-priority patent/SI22850A/sl
Application filed by Krka Tovarna Zdravil D D Novo Mesto filed Critical Krka Tovarna Zdravil D D Novo Mesto
Application granted granted Critical
Publication of DK2262486T3 publication Critical patent/DK2262486T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK09777586.0T 2008-08-01 2009-07-31 Quetiapin sammensætning DK2262486T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200800193A SI22850A (sl) 2008-08-01 2008-08-01 Pripravek kvetiapina
SI200900073 2009-03-18
PCT/EP2009/005573 WO2010012490A1 (en) 2008-08-01 2009-07-31 Quetiapine composition

Publications (1)

Publication Number Publication Date
DK2262486T3 true DK2262486T3 (da) 2013-03-25

Family

ID=41112567

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09777586.0T DK2262486T3 (da) 2008-08-01 2009-07-31 Quetiapin sammensætning

Country Status (10)

Country Link
EP (1) EP2262486B1 (da)
DE (1) DE202009018024U1 (da)
DK (1) DK2262486T3 (da)
EA (1) EA018638B1 (da)
ES (1) ES2402342T3 (da)
HR (1) HRP20130245T1 (da)
PL (1) PL2262486T3 (da)
PT (1) PT2262486E (da)
SI (1) SI2262486T1 (da)
WO (1) WO2010012490A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8440223B2 (en) 2008-07-01 2013-05-14 Lupin Limited Sustained release pharmaceutical compositions comprising quetiapine in non-gellable polymers
US20110280938A1 (en) * 2009-01-05 2011-11-17 Torrent Pharmaceuticals Limited Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
WO2011154118A1 (en) 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
US20130303632A1 (en) * 2012-05-10 2013-11-14 Fmc Corporation Controlled release solid dose form
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
CR20200486A (es) 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
GB9611328D0 (en) 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
GB9716161D0 (en) 1997-08-01 1997-10-08 Zeneca Ltd Process
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
GB9922271D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Formulation
HU227039B1 (en) 2000-01-25 2010-05-28 Egis Gyogyszergyar Nyilvanosan New process for the production of quetiapine and intermediates therefor
US6287599B1 (en) 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US20050003001A1 (en) 2001-11-07 2005-01-06 Hisami Yamaguchi Method for improving dissolution of poorly dispersible medicaments
IL164155A0 (en) 2002-03-20 2005-12-18 Teva Pharma Crystalline forms of quetiapine hemifumarate
WO2005028457A1 (en) 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
CA2542836A1 (en) 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
CN101257894A (zh) 2005-07-07 2008-09-03 法纳姆公司 高水溶性药物的缓释药物组合物
EP1928849A1 (en) 2005-09-30 2008-06-11 Fermion Oy New crystallization process of quetiapine hemifumarate
WO2008110337A2 (en) 2007-03-09 2008-09-18 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
EA020477B1 (ru) 2008-11-26 2014-11-28 Крка, Товарна Здравил, Д. Д., Ново Место Композиция кветиапина

Also Published As

Publication number Publication date
SI2262486T1 (sl) 2013-04-30
EP2262486B1 (en) 2013-01-02
ES2402342T3 (es) 2013-04-30
EA201100286A1 (ru) 2011-08-30
PT2262486E (pt) 2013-03-27
WO2010012490A1 (en) 2010-02-04
PL2262486T3 (pl) 2013-06-28
HRP20130245T1 (hr) 2013-04-30
DE202009018024U1 (de) 2010-12-09
EA018638B1 (ru) 2013-09-30
EP2262486A1 (en) 2010-12-22

Similar Documents

Publication Publication Date Title
NL301083I2 (nl) bulevirtide
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
DE602008002756D1 (de) Bauzusammensetzung
EP2381760A4 (en) CORN PROTEIN COMPOSITION
DK2634231T3 (da) Sammensætninger
BRPI0917231A2 (pt) composição
BRPI0813775A2 (pt) Composição
BRPI0907376A2 (pt) Fotobiorretador
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0914649A2 (pt) Piprazolo-quinazolinas
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
EP2144635A4 (en) STERILIZING COMPOSITION
BRPI0907522A2 (pt) biarlamidas
PT2182988E (pt) Composição radiofarmacêutica
BRPI0913606A2 (pt) composição detergente
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0909634A2 (pt) 2-aminoquinolinas
BRPI0820960A2 (pt) composição
DE112009001946A5 (de) Mobelauszugsführung
BRPI0909637A2 (pt) 2-aminoquinolinas
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas